ovarian adnexal mass

Aspira Q4 Revenues Up 11 Percent, Firm Inks Deal for Ovarian Cancer Detection Tech

InterVenn Biosciences to Develop Cancer Tests, Expand Services Business With New Funding

Aspira Q3 Revenues Down 8 Percent

William Blair Initiates Coverage of Aspira Women's Health, DermTech With Outperform Ratings

Aspira Q2 Revenues Down 32 Percent

Aspira Eyes $11M in Private Equity Financing

Vermillion Q1 Revenues Up 55 Percent

Vermillion Q4 Revenues Up 42 Percent

Vermillion Q3 Revenues Up 66 Percent

Vermillion Receives Delisting Warning From Nasdaq

Vermillion Ovarian Cancer Test Gets Coverage From BCBS of Texas, Arizona

Vermillion Q1 Revenues Up 24 Percent

Vermillion Q4 Revenues Up 16 Percent

Cigna Covering Vermillion's OVA1 Ovarian Cancer Test

Vermillion Q3 2018 Revenues Up 12 Percent

Vermillion Q2 Revenues Drop 21 Percent on Lower Test Volume

Vermillion Receives Nasdaq Delisting Warning

Vermillion Q1 Revenues Down 11 Percent